IgAN Clinical Education

Last updated: November 17, 2026

Medically reviewed by: NKF Education Team

IgA nephropathy (IgAN) is the most common glomerular disease worldwide and remains a leading cause of CKD and kidney failure. 

The following programs for healthcare professionals feature experts discussing the impact of IgAN on kidney health, highlighting evidence supporting treatment of the immune-mediated pathogenesis of IgAN, and reviewing the KDIGO 2025 Guideline recommendations for IgAN diagnosis and treatment.

IgAN Webinar Series

Part 1: Lighting the Fire in IgAN: Time is Nephron

Part 2: From the Gut to the Kidneys: How Biomarkers Are Shaping IgAN Management

Woman taking notes while looking at her laptop. Project ECHO logo

Glomerular Disease Project ECHO

Expert insights. Case-based discussions. Practical strategies for patient care.

Every Third Tuesday at 2pm ET
January – June 2027

Information contained in this NKF educational resource is based on data available at the time of publication. It is intended to help clinicians stay informed about new scientific findings and developments. This resource is not intended to establish a preferred standard of care and should not be interpreted as prescribing an exclusive course of management.
© 2026 National Kidney Foundation, Inc.